$BEAM insider trading
Over the last 12 months, Beam Therapeutics insiders reported no purchases and 22 sales totaling $19.8M across SEC Form 4 filings. 91% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $19.8M 22 events
- Events · 12m
- 22 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 91% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Simon AmyChief Medical Officer · O | ▼ Sale | 16,667 | $25.74 | $429K | -16.3% | plan |
| Jun 30, 2026 | Simon AmyChief Medical Officer · O | ▼ Sale | 373 | $34.73 | $13K | -0.4% | plan |
| Jun 30, 2026 | Evans John M.CEO · O·D | ▼ Sale | 50,000 | $34.9 | $1.7M | -4.6% | plan · 4 tranches |
| Jun 26, 2026 | FMR LLC10% | ▼ Sale | 284,860 | $35.24 | $10.0M | -25% | 2 tranches · indirect |
| Apr 1, 2026 | Evans John M.CEO · O·D | ▼ Sale | 30,078 | $24.58 | $739K | -2.8% | plan |
| Apr 1, 2026 | Simon AmyChief Medical Officer · O | ▼ Sale | 6,700 | $24.58 | $165K | -6.1% | plan |
| Apr 1, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer · O | ▼ Sale | 3,242 | $24.58 | $80K | -6% | plan |
| Apr 1, 2026 | Bellon ChristineChief Legal Officer · O | ▼ Sale | 5,956 | $24.58 | $146K | -5.1% | plan |
| Apr 1, 2026 | Ciaramella GiuseppePresident · O | ▼ Sale | 11,810 | $24.58 | $290K | -5.1% | plan |
| Mar 31, 2026 | Evans John M.CEO · O·D | ▼ Sale | 50,000 | $22.57 | $1.1M | -4.8% | plan · 2 tranches |
| Feb 24, 2026 | Ciaramella GiuseppePresident · O | ▼ Sale | 35,000 | $32 | $1.1M | -15.5% | plan |
| Jan 30, 2026 | Evans John M.CEO · O·D | ▼ Sale | 50,000 | $28.87 | $1.4M | -4.8% | plan · 4 tranches |
| Jan 22, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer · O | ▼ Sale | 6,198 | $35 | $217K | -15.1% | plan |
| Jan 22, 2026 | Bellon ChristineChief Legal Officer · O | ▼ Sale | 1,371 | $34 | $47K | -1.4% | plan |
| Jan 20, 2026 | Cavanagh Bethany JSVP, Finance and Treasurer · O | ▼ Sale | 3,034 | $30.12 | $91K | -6.9% | plan |
| Jan 15, 2026 | Bellon ChristineChief Legal Officer · O | ▼ Sale | 18,629 | $34.61 | $645K | -16.1% | plan · 3 tranches |
| Dec 31, 2025 | Emany Sravan KumarChief Financial Officer · O | ▼ Sale | 6,294 | $27.1 | $171K | -7.9% | plan |
| Dec 31, 2025 | Bellon ChristineChief Legal Officer · O | ▼ Sale | 1,254 | $27.1 | $34K | -1.1% | plan |
| Oct 27, 2025 | FMR LLC10% | ▼ Sale | 459 | $26.68 | $12K | -97% | indirect |
| Oct 2, 2025 | Evans John M.CEO · O·D | ▼ Sale | 50,000 | $24.57 | $1.2M | -4.8% | plan · 2 tranches |
| Oct 1, 2025 | Cavanagh Bethany JSVP, Finance and Treasurer · O | ▼ Sale | 467 | $24.53 | $11K | -1% | plan |
| Oct 1, 2025 | Bellon ChristineChief Legal Officer · O | ▼ Sale | 373 | $24.53 | $9K | -0.3% | plan |
Every $BEAM filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Beam Therapeutics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BEAM feed.